Evidence map›Paper›PMID 31561555›Full record

ReviewInternational journal of molecular sciences2019

Hanna Busch, Peter-Leon Hagedoorn, Ulf Hanefeld

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Whole-genomic and transcriptomic analyses elucidateApplied and environmental microbiology · 2026
    Article
  3. Article
  4. Article
  5. Draft genome sequence ofMicrobiology resource announcements · 2025
    Article
  6. Draft genome sequence ofMicrobiology resource announcements · 2025
    Article
  7. A Marine-Derived Steroid fromMarine drugs · 2025
    Article
  8. Rare Bloodstream Infection ofInfection and drug resistance · 2025
    Article
  9. Review
  10. Complete genome sequence of a novelFrontiers in genetics · 2024
    Article
  11. Article
  12. Article
  13. Biotransformation of (-)-Isopulegol byPharmaceuticals (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Article
  16. Frontiers in microbiology · 2022
    Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hanna BuschDepartment of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, The Netherlands. H.Busch@tudelft.nl.
Peter-Leon HagedoornDepartment of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, The Netherlands. P.L.Hagedoorn@tudelft.nl.
Ulf HanefeldDepartment of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, The Netherlands. U.Hanefeld@tudelft.nl.

Funding

Stichting voor de Technische Wetenschappen 14170
6 · The paper itself

Abstract

The application of purified enzymes as well as whole-cell biocatalysts in synthetic organic chemistry is becoming more and more popular, and both academia and industry are keen on finding and developing novel enzymes capable of performing otherwise impossible or challenging reactions. The diverse genus

Indexed as

Chemistry Techniques, SyntheticBiocatalysisCatalysisHydrolasesMetabolic Networks and PathwaysNitrilesOxidation-ReductionOximesRhodococcusSulfur Compoundsacetaldehyde oximeHydrolasesNitrilesOximesSulfur Compoundsbiocatalysisdrugsenzymeorganic synthesisRhodococcus

Identifiers

PMID31561555
PMCPMC6801914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.